Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan wafer for acute migraine with unilateral trigeminal autonomic symptoms
2008-007967-18Phase 3Completed
- Sponsor
- IRCCS San Raffaele Pisana
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Rizatriptan with Placebo (2 arms). Primary endpoints: Pain freedom at 2 hours, Pain relief at 2 hours and 1 more. Started Jan 2012; status: completed.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on 2008-007967-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007967-18.